Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt:

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
217
Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4): Project Pipeline Set to Swell

- Israel on brink of removing ban on export of medical marijuana
- Redfund makes first investment in cannabis beverage company Biolog Inc.
- Biolog to collaborate in initiative to develop water-soluble cannabinoids

Recent developments in regulation and research and development in the cannabis space are set to swell the project pipeline of Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4). In November, a government committee in Israel approved the first draft of a law on the export of medical cannabis, a move welcomed by the industry, with one commentator (http://nnw.fm/1hY7j) opining, “Although a small step in the dry process of legislation, it’s a huge leap forward for the industry.” Medical cannabis has been domestically available in Israel for at least two decades. Its export, however, has been prohibited, leaving untapped, some say, a market worth around $4 billion.

The course of cannabis in Israel has meandered over the years. Most notably, it was in Israel that Raphael Mechoulam and Yechiel Gaoni started research on cannabis in the 1960s, with their work eventually leading to the identification and isolation of tetrahydrocannabinol (THC), the psychotropic component in marijuana. Today, Israel continues to lead research into cannabinoids. Yet, recreational use of cannabis remains illegal and will continue to do so until April 1, 2019. Additionally, export of medical cannabis is banned. Nevertheless, change is imminent. In 2017, two Israeli government departments recommended that export of medical cannabis be given the go-ahead. A committee made up of members from the Ministries of Finance and Health estimated that the Israeli export market could be valued at one to four billion shekels ($275 million to over $1 billion).

Redfund Capital Corp. is a merchant bank focused on providing debt and equity funding to mid- and late-stage companies. The bank’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related companies. Redfund is keeping a close eye on developments in the Middle Eastern nation. The merchant bank has been performing due diligence on a number of potential target companies located there. One such company is developing technology that could change how cannabis is grown for medical cannabis patients. A second is a medical products and CDB company, while a third has research and development facilities in Israel and grow operations abroad. Redfund is looking to Israel as the next country to forge strong relationships with for its banking initiatives (http://nnw.fm/w6YoO).

In August 2018, Redfund announced that it had completed its first investment. The landmark initiative took the form of equity financing in Biolog Inc., a California-based company (http://nnw.fm/Ed3Bq). Biolog Inc. operates in the fast-growing market for CBD edibles and infused beverages. Its products are expected to employ DehydraTECH technology, under license from Lexaria Bioscience Corporation (CSE: LXX) (OTCQX: LXRP), which will enhance their taste and improve the bioavailability of active ingredients. Biolog has also announced a partnership with Cannabis Strategic Ventures, Inc. (OTC: NUGS) to develop water-soluble cannabis technologies for cannabis- and phytocannabinoid-infused foods, beverages and consumer products (http://nnw.fm/Pph5B).

Cannabinoids, including CBD, are lipophilic (akin to fats and oils) and thus not soluble in water. Various methods, such as emulsification, have been attempted to make them more so, but many drawbacks still remain. This joint effort between Biolog, Inc. and Cannabis Strategic Ventures will seek to push past these limitations to develop a new set of compounds that can be easily added to foods, beverages, cosmetics and other consumer products. The result is expected to make cannabis more usable, thus significantly improving bioavailability and overall benefits to the human body.

For more information, visit the company’s website at www.RedfundCapital.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Xtacy Therapeutics Corp. (XTCYF) Stock Research Links

XTCYF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AutoShop Answers Extends 2027 Training Into Fridays

Updated Category News Views 83

A repair bay can hum all day while the back office quietly bleeds profit. That unglamorous reality is why AutoShop Answers adding nine Friday specialty classes to its 2027 Key2Key Weekend calendar deserves a closer look. This is not a new tool chest or some vague motivational roadshow; it is an attempt to give independent shop owners an extra day to work on the pieces...

Continue Reading
Anthropic Bears Get New Tools, But Daily Risk Bites

Updated Category News Views 64

A $81.3 Billion Offering Invites Fast Money Anthropic arrived in public markets with the sort of numbers that make traders reach for both a calculator and a helmet. The company priced 980 million Class A shares at $83 on November 18, 2026, raising roughly $81.3 billion, then opened at $111.50 when it began Nasdaq trading on November 19. That is a monster debut by any...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 144

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 69

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 394

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 318

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 555

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 661

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing First Solar's Options Activity and Market Position

Updated Category News Views 169

Understanding First Solar's Recent Options Activity It's been an intriguing time for traders with First Solar, as financial giants have made noticeable bullish moves associated with the company. Our extensive analysis of the options trading history for First Solar (FSLR) indicates that there have been ten unusual trades, reflecting a significant interest among market...

Continue Reading
Wolters Kluwer's Enablon ESG Excellence Receives 2024 Award

Updated Category News Views 164

Wolters Kluwer’s Enablon ESG Excellence Recognized with Stratus Award Wolters Kluwer has made a significant mark in the information and software solutions industry with its acclaimed Enablon ESG Excellence solution. Recent accolades have highlighted the company as a leader in Software as a Service (SaaS) by the Business Intelligence Group in the prestigious Stratus...

Continue Reading
Insights and Innovations in Software Supply Chain Security

Updated Category News Views 67

Introduction to Kusari Platform The Kusari Platform is a cutting-edge innovation in the realm of software supply chain security. With the ever-increasing complexity of software systems, the need for an effective solution to manage and secure software components is crucial. The Kusari platform is tailored to ingest Software Bill of Materials (SBOM) data, providing...

Continue Reading
Innovative Electronic Street Signs Enhance Public Awareness

Updated Category News Views 332

Revolutionizing Public Communication with Electronic Signs Inventors often seek to enhance the way we communicate essential information to the public, and one such innovative creation is the electronic sign designed for streets. This invention aims to keep residents informed about various conditions such as parking restrictions, storm warnings, accidents, and detours. By...

Continue Reading
Cosmos Health Secures Major Funding for Innovative Strategy

Updated Category News Views 198

Cosmos Health Secures Significant Financing Cosmos Health Inc., a diversified global healthcare group, has recently announced a groundbreaking financing agreement. The company has entered into a securities purchase agreement aiming for up to $300 million in senior secured convertible promissory notes. This strategic move is designed to bolster Cosmos Health's new Ethereum...

Continue Reading